This "HCVc-MDSCs-TGF-β-LX2" axis establishes, for the first time, a direct link between viral infection, immunosuppressive myeloid cells, and the hepatic fibrosis process, providing potential targets for developing novel therapeutic strategies for hepatitis C-associated liver fibrosis. This evidence concerns the gene TGFB1 and Hepatic fibrosis.